180 related articles for article (PubMed ID: 26463904)
1. [Nalmefene and Opioid Withdrawal Syndrome: Analysis of the Global Pharmacovigilance Database for Adverse Drug Reactions].
Dahmke H; Kupferschmidt H; Kullak-Ublick GA; Weiler S
Praxis (Bern 1994); 2015 Oct; 104(21):1129-34. PubMed ID: 26463904
[TBL] [Abstract][Full Text] [Related]
2. [Illogical association nalmefene and opioids: Analysis in the French pharmacovigilance database].
Favrelière S; Lafay-Chebassier C; Fauconneau B; Quillet A; Yéléhé-Okouma M; Montastruc F; Pérault-Pochat MC
Therapie; 2019 Jun; 74(3):369-374. PubMed ID: 30197228
[TBL] [Abstract][Full Text] [Related]
3. Severe opioid withdrawal syndrome after a single dose of nalmefene.
Donnerstag N; Schneider T; Lüthi A; Taegtmeyer A; Raetz Bravo A; Mehlig A
Eur J Clin Pharmacol; 2015 Aug; 71(8):1025-6. PubMed ID: 26050241
[No Abstract] [Full Text] [Related]
4. Opioid substitution therapy or hidden opioids are a minefield for nalmefene: an atypical case series of 11 patients in Lorraine.
Yéléhé-Okouma M; Martini H; Lemarié J; Labroca P; Petitpain N; Gibaja V; Paille F; Gillet P
Fundam Clin Pharmacol; 2017 Oct; 31(5):574-579. PubMed ID: 28322465
[TBL] [Abstract][Full Text] [Related]
5. Assessment of nalmefene glucuronide as a selective gut opioid antagonist.
Cheskin LJ; Chami TN; Johnson RE; Jaffe JH
Drug Alcohol Depend; 1995 Aug; 39(2):151-4. PubMed ID: 8529534
[TBL] [Abstract][Full Text] [Related]
6. Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.
Franchitto N; Jullian B; Salles J; Pelissier F; Rolland B
Expert Opin Drug Metab Toxicol; 2017 Jun; 13(6):669-677. PubMed ID: 28343423
[TBL] [Abstract][Full Text] [Related]
7. ▼Nalmefene for alcohol dependence.
Drug Ther Bull; 2014 May; 52(5):54-7. PubMed ID: 24809337
[TBL] [Abstract][Full Text] [Related]
8. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
[TBL] [Abstract][Full Text] [Related]
9. Nalmefene Mistakenly Prescribed to Reduce Alcohol Consumption in Patients Under Buprenorphine Substitution Therapy Resulting in Acute Opioid Withdrawal: Management in an Emergency Setting.
Pélissier F; Rougé Bugat ME; Nubukpo P; Franchitto N
J Clin Psychopharmacol; 2016 Feb; 36(1):100-3. PubMed ID: 26658085
[No Abstract] [Full Text] [Related]
10. Extending the treatment options in alcohol dependence: a randomized controlled study of as-needed nalmefene.
Mann K; Bladström A; Torup L; Gual A; van den Brink W
Biol Psychiatry; 2013 Apr; 73(8):706-13. PubMed ID: 23237314
[TBL] [Abstract][Full Text] [Related]
11. Withdrawal syndrome caused by naltrexone in opioid abusers.
Hassanian-Moghaddam H; Afzali S; Pooya A
Hum Exp Toxicol; 2014 Jun; 33(6):561-7. PubMed ID: 23690227
[TBL] [Abstract][Full Text] [Related]
12. Nalmefene. Alcohol dependence: no advance.
Prescrire Int; 2014 Jun; 23(150):150-2. PubMed ID: 25121147
[TBL] [Abstract][Full Text] [Related]
13. [Naltrexone--prevention of recurrence in narcotic dependence and in alcoholism].
Poser W; Ehrenreich H
Internist (Berl); 1996 Oct; 37(10):1061-7; discussion 1067. PubMed ID: 9019453
[No Abstract] [Full Text] [Related]
14. A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence.
Gual A; He Y; Torup L; van den Brink W; Mann K;
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1432-42. PubMed ID: 23562264
[TBL] [Abstract][Full Text] [Related]
15. Problem drinking and low-dose naltrexone-assisted opioid detoxification.
Mannelli P; Peindl K; Patkar AA; Wu LT; Tharwani HM; Gorelick DA
J Stud Alcohol Drugs; 2011 May; 72(3):507-13. PubMed ID: 21513688
[TBL] [Abstract][Full Text] [Related]
16. Unintentional rapid opioid detoxification: case report.
Singh SM; Sharma B
Psychiatr Danub; 2009 Mar; 21(1):65-7. PubMed ID: 19270623
[TBL] [Abstract][Full Text] [Related]
17. Unexpected delirium during Rapid Opioid Detoxification (ROD).
Golden SA; Sakhrani DL
J Addict Dis; 2004; 23(1):65-75. PubMed ID: 15077841
[TBL] [Abstract][Full Text] [Related]
18. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
Setnik B; Roland CL; Goli V; Sommerville K; Webster L
J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
[TBL] [Abstract][Full Text] [Related]
19. Safety and tolerability of as-needed nalmefene in the treatment of alcohol dependence: results from the Phase III clinical programme.
van den Brink W; Strang J; Gual A; Sørensen P; Jensen TJ; Mann K
Expert Opin Drug Saf; 2015 Apr; 14(4):495-504. PubMed ID: 25652768
[TBL] [Abstract][Full Text] [Related]
20. Comparing Nalmefene and Naltrexone in Alcohol Dependence: Are there any Differences? Results from an Indirect Meta-Analysis.
Soyka M; Friede M; Schnitker J
Pharmacopsychiatry; 2016 Mar; 49(2):66-75. PubMed ID: 26845589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]